186 related articles for article (PubMed ID: 1740700)
1. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
[TBL] [Abstract][Full Text] [Related]
2. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
4. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
Karimjee S; Brada M; Husband J; McCready VR
Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
[TBL] [Abstract][Full Text] [Related]
5. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
[TBL] [Abstract][Full Text] [Related]
6. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
7. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
9. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
[No Abstract] [Full Text] [Related]
10. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
12. Gallium scanning in the management of mediastinal Hodgkin's disease.
Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
[TBL] [Abstract][Full Text] [Related]
13. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
[TBL] [Abstract][Full Text] [Related]
14. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
Burns DE; Schiffman FJ
Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
[TBL] [Abstract][Full Text] [Related]
15. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT].
Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig WD; Eichstädt H; Felix R
Rofo; 1997 Nov; 167(5):458-66. PubMed ID: 9440890
[TBL] [Abstract][Full Text] [Related]
16. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
King SC; Reiman RJ; Prosnitz LR
J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
[TBL] [Abstract][Full Text] [Related]
17. [Value of endoscopic ultrasound examination of the mediastinum in Hodgkin's and non-Hodgkin's lymphomas].
Zimmer T; Patan M; Berdel WE; Dulce MC; Riecken EO
Ultraschall Med; 1997 Apr; 18(2):67-71. PubMed ID: 9304199
[TBL] [Abstract][Full Text] [Related]
18. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
20. Negative gallium-67 citrate and positive positron emission tomography/computed tomography spleen scans, in Hodgkin's stage IV lymphoma.
Malamitsi J; Kosmidis H; Valotassiou B; Bonou I; Andreou J
Hell J Nucl Med; 2007; 10(2):116-8. PubMed ID: 17684589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]